Melatonin Supplement Companies, Latest Updates and Key Developments 2026

Who are the Melatonin Supplement Market Top Companies and What are Their Offerings?

Companies Offering

Melatonin Supplement Market Value Chain Analysis

R&D

• The R&D of the melatonin supplement focuses on the development of chronobiological delivery systems like phytomelatonin and pulsatile-release tablets.
• Key players: Life Extension, Nature’s Bounty, Natrol.

Clinical Trials and Regulatory Approvals

• The comparative efficacy against placebo, pharmacokinetics for optimal release profiles, and long-term safety in pediatric and geriatric populations are evaluated in the clinical trials and regulatory approvals of the melatonin supplements.
• Key players: Nature’s Bounty, Natrol, Neurim Pharmaceuticals.

Formulation and Final Dosage Preparation

• The formulation and final dosage preparation of the melatonin supplement involves the use of encapsulation for sustained-release profiles, fast-dissolving technology, and pectin-based gummy matrixing.
• Key players: Nature’s Bounty, Natrol, Church & Dwight.

Patient Support and Services

• The educational transparency, digital sleep coaching apps, and automated dosage reminders are provided in the patient support and services of the melatonin supplements.
• Key players: Natrol, Haleon, Olly.

Market Growth 2026-2035

The global melatonin supplement market size was estimated at USD 3.31 billion in 2025 and is predicted to increase from USD 3.8 billion in 2026 to approximately USD 13.32 billion by 2035, expanding at a CAGR of 14.94% from 2026 to 2035.

Recent Developments in the Melatonin Supplement Market

• In September 2025, an article titled "Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial" was published by Vanda Pharmaceuticals Inc. The product was approved for the treatment of Non-24-Hour Sleep-Wake Disorder and nighttime sleep disturbances, where the company is aiming to receive U.S. FDA approval for its use in the treatment of insomnia, Jet Lag Disorder, pediatric insomnia, and Delayed Sleep Phase Disorder (DSPD).
• In May 2025, the melatonin-based gummies were launched by Fytika Healthcare Products as a supplement to support sleep timing and overcome jet lag, marking their successful entry in the non-addictive sleep aid supplement market.

Get a sample of the Melatonin Supplement Market, customized just for your business needs: Download Now